Research On Digital Transformation Strategy Of Biotech Company Y

With the continuous development and application of digital technology,the digital transformation of the biopharmaceutical industry has become the trend and inevitable choice of industry development,and digital transformation can help biopharmaceutical companies optimize business processes,improve production efficiency and management efficiency,reduce costs,and improve comprehensive competitiveness.The development of the domestic biomedical industry has gradually changed from being mainly imitation and chasing short-term interests to focusing on innovation and pursuing international competition,and the entire industry is experiencing a huge shock caused by good money driving out bad money.In recent years,with the people’s pursuit of a better and healthy life,more high-quality and low-cost good drugs and new drugs,the country’s supply-side reform of the biomedical industry and the layout of international innovation competition need a more standardized biomedical industry and more global innovative and competitive biopharmaceutical companies,and the industry capital under the trend of economic downturn and investment value return requires biopharmaceutical companies to have better innovative drug pipelines and stronger operational efficiency.The combination of various factors has made biopharmaceutical companies realize that they must continuously improve their competitiveness,reduce costs and increase efficiency,improve the quality and R&D efficiency of innovative drugs,and be fully prepared to meet future challenges,which has prompted domestic biopharmaceutical companies to actively embrace digital transformation.The digitalization of the domestic biomedical industry started late,and the relevant research was relatively scattered,and there was no systematic digital transformation case study for the industry to refer to.From the perspective of the digital leader of Company Y,the author systematically presents the digital transformation strategy of typical biopharmaceutical company Y,and expects to systematically describe and characterize the digital transformation process of typical enterprises through the research of this thesis,reveal the patterns and laws based on the theoretical basis of digitalization,provide reference for the industry,and discuss the application and guiding value of relevant theories in the digital transformation of the biomedical industry in the research process.Through literature research,the author collates the research progress of digital transformation all over the world,determines that based on the theory of organizational change and strategic transformation,using the PESTEL and VRIO models to analyze the external opportunities and challenges,internal digitalization-related resources and capabilities,and then clarifies the core driving factors,focused content and advantageous resources of Company Y’s digital transformation.Before formulating the digital transformation strategy,Company Y conducted a systematic investigation on the digital transformation of biopharmaceutical industry,formulated a digital transformation blueprint and path that meets the development needs,and formulated a series of key measures to ensure the smooth implementation of the digital transformation strategy,and achieved good phased results.The authors conclude through case studies that digital transformation can enable biopharmaceutical companies to reduce costs,increase efficiency,and effectively improve competitiveness.In addition,the digital transformation strategy needs to match the company’s strategy,fully think and prepare before implementation,and control the overall situation and details in the process to ensure a smooth transformation.Digital transformation is a system engineering,the process involves organizational change within the company,although in the same industry,but different companies face different problems,they have different resource and progress of digitalization,etc.the study of company Y as a case has certain limitations,it is necessary to have more and more typical biopharmaceutical company research cases presentation,comparison and summary under the trend of digitalization,that should be better for the digital transformation of the industry to provide mature reference,promote the benign development of the industry,and create more good and new drugs which could meet people’s need and cure diseases.